Adamed is one of the ten largest pharmaceutical companies operating in Poland. Adamed is the leader in next-generation pharmaceuticals – it was the first Polish company to undertake research into innovative therapies back in 2001. To date, the company has invested 1.5 billion Polish zloty in research and development and its portfolio currently boasts around 500 products. Adamed has established industry-academia consortia with leading universities and research institutes in Poland and abroad.